Three species of mosquito are of particular concern in Europe, according to the European Centre for Disease Prevention and ...

The reemergence of dengue virus serotype 3 (DENV-3) in Brazil after 17 years could help worsen fresh outbreaks of the disease ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...

A research team has unveiled new insights into how weather influences the spread of dengue fever. The study identifies temperature and rainfall as critical factors driving the global surge in dengue ...

The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent ...

Get Instant Summarized Text (Gist) The reemergence of dengue virus serotype 3 (DENV-3) in Brazil, after 17 years, poses a risk of more severe outbreaks due to the population's lack of immunity to ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...